1. Introduction {#sec1}
===============

The epitranscriptome can serve to regulate translation through post-transcriptional modification of RNAs and its dysregulation is associated with disease and toxicant susceptibility \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6]\]. Alkylation repair homolog 8 (ALKBH8) is an epitranscriptomic writer with tRNA methyltransferase activity and it can methylate the wobble uridine on tRNA^Sec\ 7,8^. ALKBH8 is required to complete the formation of 5-methoxycarbonylmethyluridine (mcm \[[@bib5]\]U) and 5-methoxycarbonylmethyl-2′-O-methyluridine (mcm \[[@bib5]\]Um), and these RNA modifications promote UGA-stop codon recoding which is needed for the incorporation of the rare 21st amino acid selenocysteine (Sec) \[[@bib7], [@bib8], [@bib9], [@bib10]\]. We have shown that ALKBH8 protein levels, stop-codon recoding and ALKBH8-dependent uridine wobble base modifications are increased in response to reactive oxygen species (ROS) stress to improve the translation of selenocysteine containing glutathione peroxidase (GPX) and thioredoxin reductase (TRXR) enzymes \[[@bib11]\], supporting the idea that the epitranscriptomic writer ALKBH8 is a ROS sensor and effector.

Senescence is a form of replicative arrest which is triggered by a variety of stressors including but not limited to DNA damage, telomere erosion, and oxidative stress \[[@bib12]\]. While senescence is beneficial as an innate tumor-suppressive mechanism responsible for inducing permanent replicative arrest in cells at risk of malignant transformation, it has been established that the accumulation of senescent cells with increasing age is deleterious in tissue microenvironments *in vivo* \[[@bib13]\]. Upon senescent transformation, cells adopt a modulated secretome termed the senescence-associated secretory phenotype (SASP), increasing secretion of inflammatory cytokines, matrix metalloproteinases (MMPs), chemokines, and growth factors into the surrounding tissue microenvironment \[[@bib14]\]. Through its ability to evoke responses from cells in a paracrine fashion, SASP has been linked to numerous age-associated disease pathologies including tumor invasion, cardiovascular dysfunction, neuroinflammation, osteoarthritis and renal disease \[[@bib15], [@bib16], [@bib17], [@bib18]\].

While there is wealth of information linking senescence to many degenerative disease processes \[[@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22]\] the role of selenium in the regulation of the senescence program has only recently been unveiled. Se supplementation can extend the replicative lifespan of cells in culture \[[@bib23]\] and Se deprivation or supplementation can accelerate or delay the production of senescence associated markers, respectively \[[@bib23], [@bib24], [@bib25]\]. While serum selenium levels are predictors of longevity and healthy aging \[[@bib26], [@bib27], [@bib28]\] selenium deprivation has also been shown to promote longevity \[[@bib29]\]. Selenium is functionally utilized by small repertoire of enzymes as Sec, which is incorporated translationally through the use of UGA stop codon recoding and under epitranscriptomic control. However, little is known with respect to the specific contribution of epitranscriptomic writers that control Sec utilization in regulating senescence. In this study, we show that deficiency in ALKBH8 engages senescence, mitochondrial reprogramming and confers a survival advantage to cells with a limited capacity to incorporate selenocysteine. Increases in selenoncysteine containing proteins are often associated with chemoresistance and these findings indicate that therapeutic strategies to impede selenoprotein activity may further accentuate drug resistance and confer and advantageous survival advantage.

2. Materials and methods {#sec2}
========================

2.1. Cell culture {#sec2.1}
-----------------

Both wild type (WT) Mouse Embryonic Fibroblasts (MEFs) and *Alkbh8* deficient (*Alkbh8*^*de*f^ or *Def*) MEFs were cultured in Dulbecco\'s Modified Eagle\'s Medium (DMEM) (Corning Inc., Corning, NY) supplemented with 10% fetal bovine serum (Corning Inc., Corning, NY), 10% non-essential amino acids (Corning Inc., Corning, NY), 100 Units/mL penicillin and 100 μg/ml streptomycin, at 21% oxygen tension at 37 °C and 5% CO~2~. These cells were lifted in 0.25% trypsin/EDTA (Corning Inc., Corning, NY) and serially passaged at a dilution of 1:6.

Primary human fetal lung fibroblasts (IMR90) were cultured in Minimum Essential Medium (MEM) (Corning Inc., Corning, NY) supplemented with 10% fetal bovine serum and incubated at 21% oxygen tension at 37 °C with 5% CO~2~. These cells were lifted in 0.25% trypsin/EDTA and serially passaged at a dilution of 1:4.

To analyze cell viability in different oxygen concentration, cells were cultured in 21% and 3% O~2~ for 5 days and counted every 24 h.

2.2. Cytotoxicity and colony formation {#sec2.2}
--------------------------------------

10,000 cells per well were seeded in 96 well plates (Celltreat, Pepperell, MA) and were treated for 24 h with 2 deoxy-glucose (2DG) (Cayman, Ann Arbor, MI) at indicated concentrations to measure cytotoxicity. Cells were then stained with crystal violet, followed by solubilizing with 10% acetic acid and absorbance was measured with Flex Station 3 plate reader (Molecular Devices, San Jose, CA) at a wavelength of 570 nm. 500 cells per well were seeded in 24 well plates with 0.31 mM 2DG. Cells were grown for 5 days and colonies formed were stained using crystal violet. Colonies of 15 or more cells were counted for quantification and surviving fraction was calculated as (number of colonies formed/500 cells plated).

2.3. Quantitative RT-PCR {#sec2.3}
------------------------

In brief, total mRNA was extracted from respective cell lines using TRIzol reagents (Life Technologies, Carlsbad, CA) as described by manufacturer. cDNA was synthesized from 500 ng total mRNA using Maxima H Minus First strand kits (Thermo Fisher Scientific, Waltham, MA). Real-time quantitative RT-PCR was performed in triplicates on a 7500 PCR system (Applied Biosystems, Förster city, MA) and the sequences were described in [Supplementary Table 1](#appsec1){ref-type="sec"}. Additional oxidative stress and antioxidant defense regulated genes were also analyzed using RT \[[@bib2]\] profiler PCR array (Qiagen, Hilden, Germany).

2.4. Western blot {#sec2.4}
-----------------

Cell were washed twice with cold phosphate-buffered saline (PBS) and lysed with radioimmunoprecipitation (RIPA) lysis buffer. The lysates were centrifuged for 15 min at full speed at 4 °C. For sample preparation, 15 μg of whole cell lysates were used and 6X SDS sample buffer with 10% of 0.5 M DTT added to each sample prior to boiling for 15 min. The samples were then separated on an 8% SDA-polyarylamide gel (Thermo Fisher Scientific, Waltham, MA) and transferred onto nitrocellulose membrane (Thermo Fisher Scientific, Waltham, MA). The membrane was blocked with 5% dry milk in 0.1% Tris-buffered saline-Tween 20 for 1 h and incubated overnight at 4 °C with primary antibodies, UCP2 (1:400) (Santa Cruz Biotechnology, Dallas, TX), Mitofusin 1 (1:500) (Cell Signaling Technology, Danvers, MA), Mitofusin 2 (1:500) (Cell Signaling Technology, Danvers, MA), Drp1 (1:500) (Cell Signaling Technology, Danvers, MA), GAPDH (1:10000) (Santa Cruz Biotechnology, Dallas, TX), Alkbh8 (1:1000) (ABclonal, Woburn, MA), GPX1 (1:1000) (R&D Systems, Minneapolis, MN), and TRXR2 (1:1000) (ABCAM, Cambridge, MA) followed by incubation with respective secondary antibodies, either anti-mouse (1:10000) (Cell Signaling Technology, Danvers, MA), anti-goat(1:10000) (ABCAM, Cambridge, MA) or anti-rabbit (1:10000) (Cell Signaling Technology, Danvers, MA) for 1 h. The membranes were developed by Supersignal West Femto Maximum sensitivity substrate kit (Thermo Fisher Scientific, Waltham, MA) and imaged with ChemiDoc^TM^ imaging system (BIO-RAD, Hercules, CA).

2.5. SA-β-gal staining {#sec2.5}
----------------------

Senescence Associated β-Galactatosidase (SA-β-Gal) staining was performed using senescence-galactosidase staining kit (Cell Signaling Technology, Danvers, MA) as per manufacturer\'s protocol. Briefly, cells were seeded in 6-well tissue culture plates overnight and washed once with PBS. 1 ml of 1x fixative solution was added and incubated for 15 min at room temperature. The plates were washed twice with PBS and stained with 1 ml of β -Gal staining solution for overnight at 37 °C in a dry non-CO~2~ incubator. Images were taken in nine random fields using light microscopy and β-gal-positive cells are presented as intensity normalized to WT MEFs using ImageJ software.

2.6. Heterochromatin foci staining {#sec2.6}
----------------------------------

Cells were seeded on coverslips in 6-well tissue culture plates overnight, followed by fixation of the cells with cold 4% formaldehyde solution for 15 min at room temperature. The plates were washed once with cold PBS and the coverslips were mounted on glass slides with Prolong^TM^ Gold Antifade Mount containing DAPI (Thermo Fisher Scientific, Waltham, MA). The slides were left overnight to dry in the dark and sealed with clear nail polish. Images were taken in three random fields using florescent microscope and heterochromatin foci positive nuclei are presented as percentage of total number of counted nuclei.

2.7. Mitochondrial oxygen consumption rate {#sec2.7}
------------------------------------------

Oxygen Consumption rate (OCR), and extracellular acidification rate (ECAR) were measured at 37 °C as per manufacturer\'s protocol for the seahorse XF24 extracellular flux analyzer (Agilent Technologies, Santa Clara, CA). Briefly, cells were seeded in 24-well tissue culture plate overnight, allowing the cells to adhere. Due to differences in proliferative capacity between cell types, cells were seeded at differing densities so that cell numbers were equivalent at time of metabolic flux analysis. On the day of analysis, Cells were changed to conditional seahorse assay media at pH 7.4 supplemented with 25 mM glucose and 1 μM sodium pyruvate. Cells were incubated in non-CO~2~ incubator at 37 °C for 1 h and respiration was measured before and after injection of three compounds: oligomycin (1 μM), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (3 μM), and rotenone (1 μM). Immediately after the run, cells were lysed in RIPA buffer and the protein concentration was measured using BCA assay. The results were normalized with the protein OD value of corresponding wells and OCR, ECAR and cell energy phenotype were automatically calculated by Wave software (Agilent Technologies, Santa Clara, CA).

2.8. Mitotracker green staining {#sec2.8}
-------------------------------

Cells were seeded on cover-slips for 24 h to reach desired confluency. The cells were then stained with 200 nM MitoTracker Green (Invitrogen, Carlsbad, CA) and incubated for 15 min at 37 °C. After incubation period, cells were washed once with PBS and fixed with 4% formaldehyde solution for 15 min at room temperature. The plates were then washed once with cold PBS and the coverslips mounted on glass slides with Prolong^TM^ Gold Antifade Mount. The slides are immediately imaged using 60x oil immersion objective (Zeiss, Oberkochen, Germany). The morphology and the length of the mitochondria are measured using Fiji-ImageJ \[[@bib30],[@bib31]\]. Briefly, MiNA macro tool was installed in Fiji from <https://github.com/ScienceToolkit/MiNA> as per instructions. After opening the images with Fiji software, granular noise is remover (process →Noise→Despeckle) and local contrast enhancement performed to improve the binary image quality, as well as better visualization of small, dendritic mitochondria (Process→Enhance Local Contrast (CLAHE). Plugins→Analyze→Tubeness was perform to see the mitochondrial network. And the morphology of the mitochondria were analyzed in following steps; Process→Binary→Make Binary, Process→Binary→skeletonize, Analyze→Skeleton→Analyze Skeleton(2D/3D), and Plugins→Stuart Lab→MiNA Scripts→MiNA Analyze Morphology.

2.9. 2′,7′-dichlorodihydrofluorescein diacetate (H~2~DCFDA) staining {#sec2.9}
--------------------------------------------------------------------

Cells were seeded in 96-well black/clear bottom plate with or without 20 μM genipin treatment overnight. On the day of assay, the cells were washed once with PBS, and treated with 300 μM H~2~O~2~ for 30 min at 37 °C. The cells were then washed once with PBS and stained with 30 μM cell-permeant oxidation-sensitive dye H~2~DCFDA (Invitrogen, Carlsbad, CA) for 30 min at 37 °C, followed by fluorescence analysis (485 nm excitation, 535 nm emission) with Flex Station 3 plate reader. The oxidation-insensitive dye 5(6)-carboxyl-2′,7′-dichlorodihydrofluorescein diacetate (CDCF) (Invitrogen, Carlsbad, CA) was used as control so that any fluorescence changes between groups with H~2~DCFDA is directly attributed to changes in the dye oxidation. Mean fluorescent values for H~2~DCFDA-treatment cells were normalized to values of the control CDCF-treated cells.

2.10. Statistical methods {#sec2.10}
-------------------------

Data were analyzed using GraphPad Prism version 8 software. All statistical analyses were performed with the GraphPad Prism 8.0 statistical software package. Statistical significance was assessed using the two-tailed Student\'s *t*-test or one-way ANOVA with Tukey-Kramer post-test. P values of \<0.05 were considered significant.

3. Results {#sec3}
==========

3.1. *Alkbh8* deficient cells engage cellular senescence {#sec3.1}
--------------------------------------------------------

We have established *that Alkbh8* deficiency limits selenoprotein synthesis, elevating cellular ROS levels \[[@bib11]\] ([Supplementary Figure 1](#appsec1){ref-type="sec"}**)**, and that increases in steady state H~2~O~2~ production drive SASP \[[@bib14]\]. We first performed a focused array using Qiagen\'s Oxidative Stress and Antioxidant Defense RT \[[@bib2]\] Profiler PCR Array to evaluate potential adaptive oxidant metabolizing genes that aid in the survival of cells deficient in *Alkbh8* and the absence of many functional key selenocysteine containing proteins. [Supplementary Table 2](#appsec1){ref-type="sec"} summarizes our findings indicating that there is a robust increase in the levels of number of key oxidant-metabolizing genes, including Superoxide dismutase 2 (*Sod2*), neutrophil cytosol factor1 (*Ncf1*), Uncoupling protein 2 and 3 (*Ucp2* and *Ucp3*) and glutathione peroxidase 3 and 6 (*Gpx3* and *Gpx6*). Indicating that selenoprotein deficiency is accompanied by adaptive increases in the transcripts of oxidant-metabolizing genes. We next evaluated whether the increased oxidizing capacity of *Alkbh8*^*def*^ cells activate the senescent program. We first characterized the proliferative capacity of *Alkbh8*^*def*^ cells as cellular senescence is accompanied by growth arrest. As shown in [Fig. 1](#fig1){ref-type="fig"}A, *Alkbh8*^*def*^ MEFs display a significant proliferative defect, compared to their WT controls, that is reversed by growth in low oxygen (3% O~2~). The tumor suppressor *p16*^*INK4a*^ has been well established as a senescence marker and its expression was significantly upregulated in *Alkbh8*^*def*^ MEFs ([Fig. 1](#fig1){ref-type="fig"}B**)** while the cell cycle regulator *p21* was not. We next set out to determine if replicative senescence, which is observed in primary human diploid cells, is accompanied by alterations in the levels of *Alkbh8*. Transcript levels of *Alkbh8* were decreased in senescent IMR-90 human diploid fibroblasts, relative to pre-senescent cells, which was reversed by culturing cells in 3% O~2~ ([Fig. 1](#fig1){ref-type="fig"}C). These, observations suggest that *Alkbh8* depletion is associated with proliferative defects linked to the senescence program.Fig. 1***Alkbh8* deficiency impedes cell growth, induces *p16Ink4a* and is observed in senescent human diploid fibroblast IMR-90 cells. A)** Growth of *Alkbh8*^*def*^ and WT MEFs in 21% and 3% O~2~. **B)** RT-PCR transcript levels *p16*^*Ink4a*^ and *p21* from wild type (WT) and *Alkbh8 deficient (def)* cells. All data was normalized to *β-actin* controls. Data shown are the mean ± SEM, \*\*\*, p ≤ 0.001 when compared to WT. **C)** RT-PCR transcript levels of *Alkbh8* from young and old (senescent) human diploid fibroblast IMR90 cells culture in low and high oxygen. Data shown are the mean ± SEM, \*\*\*, p ≤ 0.001.Fig. 1

Cellular senescence is also associated with the formation of heterochromatin foci (HCF), which are enriched in chromatin modifications. HCF can be monitored using high magnification fluorescence microscopy in combination with DAPI staining as in [Fig. 2](#fig2){ref-type="fig"}A, demonstrating significant enrichment of HCF in *Alkbh8*^*def*^ MEFs. Senescence associated beta-galactosidase (SA-β-gal) is also a key indicator of senescence engagement and can be detected at pH 6 in single cells using X-Gal staining \[[@bib32]\]. *Alkbh8*^*def*^ cells display significant increases in SA-β-gal staining compared to WT ([Fig. 2](#fig2){ref-type="fig"}B**).** The senescence associated secretary phenotype is common to all forms of senescence and is causal to age-related decline in organ function \[[@bib33]\]. We have established that the senescence associated secretory phenotype is under redox-control \[[@bib14]\] and it is likely that oxidative stress that accompanies the impairment in selenoprotein exacerbates SASP. As shown in [Fig. 3](#fig3){ref-type="fig"}, the levels of many of the most prominent SASP markers are dramatically upregulated when selenocysteine utilization is impaired by *Alkbh8* deficiency. Further, Alkbh8 rescue negated any increases in SASP and HCF observed in the *Alkbh8*^*def*^ cells ([Supplementary Figure 2](#appsec1){ref-type="sec"}). Thus, *Alkbh8* deficiency is clearly responsible for the increase in senescent marks.Fig. 2***Alkbh8* deficiency increases senescence associated heterochromatic foci and senescence associated β-galactosidase levels. A)** WT and *Alkbh8*^*def*^ MEFs stained with DAPI (*left panels*) and imaged at differing fluorescence intensities (upper and lower panels) to accentuate stained nuclei. Quantification of HCF (*n* = 5), (*right panel).***B)** Senescence-Associated β-galactosidase staining of WT and Alkbh8^def^ MEFs (*left panels*) and quantification (*n* = 3), (*right panel).* Data shown are the mean ± SEM, \*\*, p ≤ 0.01 and \*, p ≤ 0.05 for A and B, respectively.Fig. 2Fig. 3***Alkbh8* deficiency engages the Senescence Associate Secretory Phenotype.** RT-PCR of indicated SASP transcripts in control and *Alkbh8*^*def*^ MEFs (n = 3). Data shown are the mean ± SEM, \*, p ≤ 0.05, \*\*, p ≤ 0.01, \*\*\*, p ≤ 0.001 when compared to WT.Fig. 3

3.2. *Alkbh8* deficiency engages mitochondrial reprogramming {#sec3.2}
------------------------------------------------------------

Mitochondrial fusion has also been shown to play an important role in adapting to stress and increased fusion events are correlated with senescence \[[@bib34],[@bib35]\]. To determine if a deficiency in the epitranscriptomic writer ALKBH8 alters mitochondrial morphology, we performed mitochondrial staining using mitotracker green in combination with Fiji-ImageJ. *Alkbh8*^*def*^ cells display a significant increase in mean mitochondrial length and mean summed branch length when compared to WT, while other mitochondrial network parameters remain the same. ([Fig. 4](#fig4){ref-type="fig"}A**,** [Supplementary Fig. 3](#appsec1){ref-type="sec"}). Fusion serves a protective function in response to cell stress \[[@bib36]\] and is controlled by key fusion (MFN1, MFN2 and OPA1) and fission associated proteins (FIS1 and DRP1). Analysis of a subset these fusion and fission proteins revealed no change in the levels of the fusion proteins MFN1 and MFN2 but a striking decrease in the levels of the fission protein DRP1 ([Fig. 4](#fig4){ref-type="fig"}B**)** in *Alkbh8*^*def*^ cells. Decreases in the levels of fission to fusion related proteins may in part explain the elongated mitochondrial structure in the *Alkbh8* deficient MEFs. Overall, the above findings support the idea that mitochondria play an important role in adapting to epitranscriptomic defects.Fig. 4***Alkbh8* deficiency is accompanied by increases in mitochondrial length which is associated with a decrease in fission related protein DRP1. A)** WT and *Alkbh8*^*def*^ MEFs were stained with 200 nM Mitotracker green for 15 min and live-imaged using Zeiss Z1 inverted fluorescence microscope. The lengths of 100 randomly selected mitochondrial were measured using ImageJ (n = 10). The box plots show median (middle Horizontal lines), first to third quartile (box), and min and max (outer horizontal lines) with \*, p ≤ 0.05. **B)** Immunoblot analysis of fission and fusion proteins from WT and *Alkbh8*^*def*^ cells and accompanying quantitative analysis (n = 3). Data shown are the mean ± SEM, \*\*\*, p ≤ 0.001 for mitochondrial length and \*, p ≤ 0.05 for DRP1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 4

3.3. *Alkbh8* deficiency engages mitochondrial reprogramming {#sec3.3}
------------------------------------------------------------

The resulting increase in mitochondrial length that accompanies *Alkbh8* deficiency led us to investigate mitochondrial function. We monitored mitochondrial oxygen consumption and glycolytic flux in *Alkbh8*^*def*^ MEFs using the XF24 Analyzer (Seahorse Biosciences). Due to differences in proliferative capacity between cell types ([Fig. 1](#fig1){ref-type="fig"}A) and the need for standard 24-h plate equilibration, cells were seeded at differing densities so that cell numbers were equivalent at time of metabolic flux analysis. *Alkbh8*^*def*^ MEFs display significant increases in basal, maximal and non-mitochondrial respiration and extracellular acidification compared to WT MEFs ([Fig. 5](#fig5){ref-type="fig"}A and B). The cell energy phenotype indicates that *Alkbh8*^*def*^ MEFs display energetic adaptation utilizing both aerobic and glycolytic metabolism in response to mitochondrial stress ([Fig. 5](#fig5){ref-type="fig"}C) which is also reversed by *Alkbh8* rescue ([Supplementary Fig. 4](#appsec1){ref-type="sec"}**).**Fig. 5***Alkbh8* deficiency is accompanied by an increase oxygen consumption and extracellular acidification. A)** Extracellular Flux analysis of WT and *Alkbh8*^*def*^ MEFs using XF24 analyzer. The graphs represent the kinetic profiles of oxygen consumption rate (OCR), and extracellular acidification rate (ECAR) in WT and *Alkbh8*^*def*^ MEFs. **B)** The bar graph represents the quantitative analysis of basal respiration, ATP production, non-mitochondrial respiration, proton leak, maximal respiratory, and reserve respiratory capacity. Cell energy phenotype display shift toward glycolysis in *Alkbh8*^*def*^ MEFs. The data represents mean ± SEM, n = 5, \*, p ≤ 0.1, \*\*, p ≤ 0.01. **C)** Cell energy phenotype profile was obtained using XF report generator. All data are calculated and displayed as absolute OCR vs. absolute ECAR. Baseline OCR and ECAR (presented as open markers) are calculated from the last rate measurement before any injection and the stressed OCR and ECAR (presented as filled markers) represent the maximum rate measurement after FCCP injection.Fig. 5

3.4. UCP2 plays a role in mitochondrial adaptation observed in *Alkbh8*^*Def*^ {#sec3.4}
------------------------------------------------------------------------------

Uncoupling protein 2 (*Ucp2*) was one of the most highly expressed genes in our focused array analyses and its expression has been reported to increase upon irradiation induced senescence \[[@bib37]\], thus we tested whether its upregulation might explain the altered functional activity of mitochondria in the *Alkbh8*^*def*^ cells. UCP2, is found in the inner mitochondrial membrane and plays a key role in uncoupling ATP synthase from electron transport chain as well as in limiting mitochondrial ROS production by decreasing electron leak \[[@bib38]\]. We first confirmed its expression at both the transcript and protein levels ([Fig. 6](#fig6){ref-type="fig"}A). Interestingly, limiting metabolic oxygen exposure with low oxygen (3% O~2~) tempered the elevations in Ucp2 expression that accompany Alkbh8 deficiency. The effects of elevated UCP2 on mitochondrial function vary and both inhibitory as well stimulatory activity have been observed \[[@bib39]\].Fig. 6***Alkbh8***^***def***^**drives UCP2 upregulation and augments metabolic flux. A)** UCP2 expression in *Alkbh8*^*def*^ MEFs. All data was normalized to GAPDH controls and presented as mean ± SEM. \*\*\*, p ≤ 0.001 when compared to WT, ^\#\#^, p = 0.003 when compared to 21% O~2~*Alkbh8*^*def*^. Inset, representative UCP2 immunoblot (n = 3) and densitometry obtained using ImageJ. \*\*, p ≤ 0.01 when compared to WT. **B)** Cell Mito Stress analysis as in [Fig. 5](#fig5){ref-type="fig"} with n = 3 **C)** Cell energy phenotype as in [Fig. 5](#fig5){ref-type="fig"} with n = 3.Fig. 6

We next measured mitochondrial oxygen consumption and extracellular acidification in *Alkbh8*^*def*^ MEFs but in the presence and absence of the UCP2 inhibitor genipin. As in [Fig. 5](#fig5){ref-type="fig"}, *Alkbh8*^*def*^ MEFs display significant increases in basal, maximal and non-mitochondrial respiration and extracellular acidification compared to WT MEFs, both of which are negated by treatment with UCP2 inhibitor, genipin ([Fig. 6](#fig6){ref-type="fig"}B). In addition, the cell energy phenotype indicates that *Alkbh8*^*def*^ MEFs display energetic adaptation utilizing both aerobic and glycolytic metabolism in response to mitochondrial stress and this adaptation is not observed when cells were treated with genipin ([Fig. 6](#fig6){ref-type="fig"}C). These findings not only confirm that UCP2 is abundantly expressed in the *Alkbh8*^*def*^ cells but that its expression is of functional significance.

3.5. *Alkbh8*^*Def*^ cells rely on glycolysis for survival and are resistant to arsenic containing mitochondrial toxins {#sec3.5}
-----------------------------------------------------------------------------------------------------------------------

As the *Alkbh8*^*def*^ cells display a glycolytic adaptation in their cell energy phenotype, we evaluated their sensitivity to the glycolytic inhibitor 2-deoxyglucose (2DG). *Alkbh8*^*def*^ are significantly more sensitive to 2DG than their WT counterparts ([Fig. 7](#fig7){ref-type="fig"}A**)**. In addition, while the *Alkbh8*^*def*^ MEFs display a proliferative defect to growth in ambient air, they are unusually resistant to a number of arsenicals which have been shown modulate mitochondrial ROS levels \[[@bib40]\] ([Supplementary Figure 5](#appsec1){ref-type="sec"}) and display self-sufficiency (high clonogenic activity) relative to WT MEFs that is blocked in response to 2DG treatment ([Fig. 7](#fig7){ref-type="fig"}B) which is reversed by Alkbh8 rescue ([Supplementary Figure 6](#appsec1){ref-type="sec"}).Fig. 7***Alkbh8***^***def***^**increases sensitivity to glycolytic inhibition. A)** Cytotoxicity assay using crystal violet stain was performed with 2DG treatment at various dosages for 24 h. **B)** Clonogenicity of WT and *Alkbh8*^*def*^ MEFs. The statistical comparison between untreated versus treated cells was presented as mean ± SEM, \*\*\*\*, p ≤ 0.0001 and ^\#\#\#\#^, p ≤ 0.0001 compared to *Alkbh8*^*def*^ 2DG treated. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 7

4. Discussion {#sec4}
=============

**Epitranscriptomic writer deficient cells adapt by engaging senescence, reprogramming stress response systems and altering mitochondrial function.**

Our previous work demonstrated cellular senescence increases H~2~O~2~ production and engages the senescence associated secretory phenotype (SASP) \[[@bib41], [@bib42], [@bib43], [@bib44]\]. Our objective here was to determine whether defects in an epitranscriptomic writer linked to Sec utilization leads to a similar redox-based activation of the senescent program. Here we report that selenoprotein loss resulting from *Alkbh8* deficiency limits H~2~O~2~ removal and engages the senescence program. Selenoprotein loss resulting from selenium restriction can also induce senescence which is reversed by selenium supplementation \[[@bib24],[@bib45]\]. The *Alkbh8*^*def*^ mice may therefore be a good model to mimic a dietary loss of selenium. As *Alkbh8* deficiency increases DNA damage and enhances basal oxidant production \[[@bib11]\], we first demonstrated that *Alkbh8*^*def*^ MEFs display a proliferative defect, which is reversed when cells are cultured in a low oxygen condition. The ability of low oxygen to delay senescence associated proliferative defects was first reported by Ames and confirmed by others \[[@bib46],[@bib47]\] and similar to these reports the reversal of the growth impediment of the *Alkbh8*^*def*^ MEFs is likely attributed to reduction in metabolic H~2~O~2~.

While senescence engagement is only one mechanism by which cells adapt to oxidant burden, they often compensate by increasing antioxidant enzyme levels or limiting mitochondrial electron leak \[[@bib48]\]. The compensatory increase in many redox modifying genes is likely, in part, responsible for the enhanced stress resistance of *Alkbh8*^*def*^ cells. Interestingly many of these oxidant metabolizing systems are commonly upregulated during carcinogenesis, oncogenic transformation and metastatic disease \[[@bib49]\].

Like senescent cells, *Alkbh8*^*def*^ MEFs display increased mitochondrial mass, ROS production, oxygen consumption and decrease ATP production \[[@bib50]\]. A number of ALKBH family members have also been linked to defects in mitochondrial function. ALKBH1 is involved in biogenesis of 5-formyl-2′-O-methylcytidine (f5Cm) at position 34 and loss *Alkbh1* decreases mitochondrial translation and reduced respiratory complex activities \[[@bib51]\]. ALKBH7 can trigger the collapse of mitochondrial membrane potential, energy depletion, and loss of mitochondrial function, which leads to oxidation induced programmed necrosis \[[@bib52]\]. Thus, defects in the ALKBH family activity cause mitochondrial dysfunction with the potential to increase ROS production promote DNA damage and senescence growth arrest \[[@bib53]\].

Mitochondria also cope with stress by controlling fusion/fission processes \[[@bib54]\] and mitochondrial elongation is a common phenotype in response to energy stress involved in tumor cell survival \[[@bib55]\]. The length of mitochondria and its dynamics are determined by the balance between fusion (MFN1, MFN2 and OPA1), and fission proteins (FIS1 and DRP1) \[[@bib56],[@bib57]\]. The ratio of fusion and fission proteins is critical in disease-related processes such as apoptosis, mitophagy and cell survival \[[@bib58]\]. Mitochondrial fusion has also been shown to play an important role in adapting to stress and increase in fusion events are correlated with senescence \[[@bib34]\]. Loss of UCP2 is associated with an increase in fragmentation and decrease in the ratio of fusion/fission related proteins which is reversed by UCP2 overexpression \[[@bib59]\], indicating that UCP2 may assist in driving the fusion processes. Our findings indicate that although no change was detected in MFN1 and MFN2 levels, *Alkbh8*^*def*^ MEFs display a significant decrease in the fission protein, DRP1, resulting in an increase of ratio of fusion and fission which likely promotes mitochondrial elongation. Whether this is a UCP2 mediated process remains to be determined.

Increased UCP2 has been reported to limit mitochondrial oxidant production and participate in many physiological processes including glucose and fatty acid utilization \[[@bib60]\] and linked to type 2 diabetes and cancer \[[@bib61], [@bib62], [@bib63], [@bib64], [@bib65], [@bib66], [@bib67], [@bib68]\]. Arsenic containing compounds are mitochondrial toxins that disrupt ATP production and are often lethal to normal cells \[[@bib69],[@bib70]\]. Thus, increased UCP2 may promote survival of the *Alkbh8*^*def*^ MEFs in response to arsenic by limiting ROS production. Resistance to arsenic containing compounds but high sensitivity to 2DG indicates that glycolytic adaptation is also important to the survival of *Alkbh8*^*def*^ MEFs. While the proliferative capacity of *Alkbh8*^*def*^ MEFs is also impaired they display a significant survival advantage when grown at low seeding density compare to the WT MEFs. High clonogenic activity, stress resistance and a reliance on glycolysis for survival are key features of tumorigenic cell lines \[[@bib71]\] and it is possible that conditions which limit ALKBH8 activity may potentiate tumorigenic activity.

4.1. Epitranscriptomic defects and adaptive phenotypes can be exploited to kill senescent cells {#sec4.1}
-----------------------------------------------------------------------------------------------

It is clear from our findings that cells adapt dramatically to the loss of ALKBH8 and defects in selenoprotein levels. In addition to mcm \[[@bib5]\]U and mcm \[[@bib5]\]Um modifications by ALKBH8, tRNA^Sec^ contains 2 modified bases at the T-arm, 1-methyladenosine (m^1^A) at position 58 and pseudouridine (Ψ) at position 55, and one modified base at anti-codon arm, N \[[@bib6]\]-isopentenyl-adenosine (i^6^A) at position 37 \[[@bib72]\]. m^1^A modification is required for Ψ synthesis, which is essential for maintaining the tertiary structure of tRNA^Sec^ \[[@bib73]\]. I^6^A modification of tRNA^\[Ser\]Sec^ catalyzed by tRNA isopentenyltransferase 1 (TRIT1) is required for decoding of UGA stop codon, as well as selenoproteins synthesis \[[@bib74]\] and knock down of TRIT1 reduces selenoprotein expression \[[@bib75]\]. Whether selenoprotein defects can engage cellular senescence and the relation between other epitranscriptomic modifications of tRNA^Sec^ and cellular senescence need to be further investigated.

Senescence has emerged as a key therapeutic target for many disease interventions as its abatement in distinct murine models limits age related decline in cognitive, cardiac and renal function, muscle atrophy, cataracts and delays tumor burden \[[@bib19],[@bib76]\]. Senescent abatement has been shown to delay atherosclerosis, pulmonary fibrosis, neurodegenerative disease, heart failure and tumor onset \[[@bib15],[@bib77], [@bib78], [@bib79], [@bib80], [@bib81]\]. We demonstrate that the UCP2 inhibitor, genipin, negated increases in mitochondrial OCR in *Alkbh8*^*def*^ MEFs, as well as their glycolytic behavior. Our study is an early example of how an epitranscriptomic defect can be metabolically exploited to limit cell growth and may have potential applications in killing tumors with similar genetic profiles.

We have previously reported that the SASP is redox-regulated through a mechanism that involves redox-dependent transcriptional activation and impeding inhibitory signaling phosphatases \[[@bib14]\]. Selenium deprivation has been established to engage senescent programming and our findings further support the importance of selenoproteins in this process likely through a similar redox based signaling process. Our study further indicates that additional, adaptive responses are engaged in response to selenoprotein deficiency. Senescence engagement coupled with stress resistance would create a microenvironment that is ripe for disease development and that targeting the epitranscriptome in combination with selenium supplementation may prove useful as a therapeutic strategy for disease intervention (See [Fig. 8](#fig8){ref-type="fig"}).Fig. 8Epitranscriptomic systems that regulate selenoprotein levels modulate senescence and mitochondrial function.Fig. 8
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